Oct 2025
Rosetta Omics was selected for the Biotechnology Venture Readiness Program 2025, opening doors in the GCC and MENA regions.
Oct 2025
An acceleration program by Pfizer and WILCO: 9 months of personalised mentorship to amplify our impact.
26 Sep 2025
A strategic collaboration with the University of Strasbourg, ESBS and INSERM begins as Prof. Bagnard joins our Scientific Advisory Board.
Oct 2025
Rosetta Omics joined the ESAC (European Society for Advanced Cancer) Network to strengthen its position in European oncology innovation.
20 Sep 2025
Third International Consulting Project (ICP) with ESCP designs Rosetta Omics' go-to-market strategy in the USA.
Sep 2025
Rosetta Omics was awarded the 1st European Innovation Prize among the top 20 European companies at HTID 2025 in Paris.
Sep 2025
Leonardo Cunha joins our Business Advisory Board, bringing global expertise in M&A, growth strategy, and internationalisation.
4 Sep 2025
Dr. Wahid Awad participated in the AI & Cancer Sector Day at Bercy, fostering dialogue across France's oncology innovation ecosystem.
Aug 2025
Rosetta Omics completed its first POC study in Colon Cancer, validating its predictive multiomics approach.
Aug 2025
Dr. Wahid Awad was elected Executive Board Member of Medicen Paris Region, representing pharma, biotech, medtech and diagnostics SMEs.
Aug 2025
Prof. Magali Svrcek, world expert in gastro-intestinal pathology and AI in pathology, joined our Scientific Advisory Board.
Aug 2025
We completed our second POC study in CRC, three times the size of the first, in partnership with a major French university hospital.
5–6 Jun 2025
Dr. Wahid Awad participated in the 4th edition of the Viv Healthtech conference in Bordeaux.
Mar 2025
Rosetta Omics was selected among the Deep Tech Pioneers, out of 4,600 applications from 120 countries.
Mar 2025
Dr. Tanya Aneichyk, founder & CEO of OmicsChart, joins the Advisory Board to support our biomarker and pharma strategy.
Feb 2025
Anne De Landsheer joins the Advisory Board, bringing 16+ years in pharma executive search and talent management.
Feb 2025
Rosetta Omics joined the first cohort of the UM6P #NextAfrica program, partnered with STATION F and WILCO.
14 Jan 2025
Rosetta Omics partnered at the RESI conference during the J.P. Morgan Healthcare Week in San Francisco, USA.
Jan 2025
Dr. Hatem Azim, leading medical oncologist and clinical development consultant, joined our Scientific Advisory Board.
11 Dec 2024
Dr. Wahid Awad pitched Rosetta Omics to investors during the HealthTech Investor Summit in Bruges, Belgium.
Dec 2024
Dr. Antoine Hollebecque, senior medical oncologist at Gustave Roussy, joins our Scientific Advisory Board.
Oct 2024
Dr. Mohamed Amine Bani from Gustave Roussy joins our Advisory Board to deepen our pathology expertise.
Jul 2024
First International Consulting Project with ESCP launched at the Agoranov incubator with a top-tier Executive MBA team.
Jun 2024
Rosetta Omics secured a Bpifrance BFT Émergence grant to finance two proof-of-concept studies in solid tumors.
May 2024
Rosetta Omics joined the prestigious Agoranov incubator in Paris.
Apr 2024
Rosetta Omics joined France Biotech, the leading voice of the French biotech ecosystem.
Feb 2024
Rosetta Omics joined a €1.5M consortium led by Maastricht University on early detection of osteoarthritis.
2024
Rosetta Omics is featured in the 3rd edition of the AI for Health French Startups Mapping.
8 Nov 2023
Dr. Wahid Awad pitched Rosetta Omics at the entrepreneurship festival of ESCP's Blue Factory incubator.
2023
Dr. Wahid Awad gave a guest lecture on entrepreneurship in biopharma at Grenoble Ecole de Management.
Hover any card to see the key points.
11–12 Jun 2026
Amsterdam, Netherlands
Our CEO Dr. Wahid Awad will be attending to discuss precision oncology, multiomics and AI-driven cancer care.
Mar 2026
Paris, France
With action comes hope! We met visitors at our stand in the health section, in partnership with UM6P GLOBAL HUBS France. Special thanks to Mr. Jean-Pierre Farandou (Ministre du Travail et des Solidarités de France) for stopping by and for the great conversation. We were also delighted to introduce our new team member Aurore Ducamp. Rosetta Omics is changing the paradigm of cancer care by unlocking the road to precision medicine.
20 Nov 2025
Palais des Congrès d'Issy-les-Moulineaux
Dr. Wahid Awad attended this leading academic event focused on early-phase cancer research.
13–14 Nov 2025
Basel, Switzerland
We connected with the tri-national ecosystem bridging Switzerland, France, and Germany.
3–5 Nov 2025
Vienna, Austria
We met investors, biotech and pharma leaders to advance partnerships in oncology and precision medicine.
Oct 2025
Boston, USA
A productive exchange that led to our selection in the Saudi Biotechnology Venture Readiness Program 2025.
Sep 2025
Paris, France
We received the 1st European Innovation Prize among the top 20 European companies.
Jun 2025
Paris, France
Rosetta Omics joined Europe's largest tech event to showcase how AI and spatial multiomics are reshaping oncology.
Mar 2025
Paris, France
Selected among the Deep Tech Pioneers, we connected with leading deeptech investors and operators worldwide.